Computer-assisted Cognitive-Behavior Therapy for Depression in Primary Care

March 12, 2025 updated by: Jesse H Wright, University of Louisville

Dissemination of Computer-assisted Cognitive-behavior Therapy for Depression in Primary Care

Computer-assisted cognitive-behavior therapy, a treatment that has been shown to be effective in previous studies in psychiatric settings, will be disseminated into primary care - a health care setting where there are significant problems in receiving adequate treatment for depression. Computer-assisted cognitive-behavior therapy will feature a low-cost method of delivering therapy designed to be replicated and sustained in other primary care settings. Feasibility and effectiveness will be tested by randomly assigning 320 primary care patients with depression to receive either computer-assisted cognitive-behavior therapy or treatment as usual.

Study Overview

Detailed Description

Computer-assisted cognitive-behavior therapy (CCBT) for depression in primary care will be evaluated in a trial with 320 patients randomly assigned to CCBT or treatment as usual (TAU). The study will disseminate a therapy method found to be effective in psychiatric settings into primary care - a setting where there have been significant problems in delivery of adequate, evidence-based treatment for depression. The study will include a high percentage of disadvantaged patients - a population that has been largely ignored in previous research in CCBT. There have been no previous studies of CCBT for depression in primary care that have enrolled large numbers of disadvantaged patients. The form of CCBT used in this study is designed to increase access to effective therapy, provide a cost-effective method, and be a sustainable model for wide-spread use in primary care.

In order to deliver therapy in a practical manner that can be replicated in other primary care practices, patients with significant symptoms of depression will receive treatment with an empirically supported computer program that builds cognitive-behavior therapy skills. Support for CCBT will be provided by telephone and/or e-mail contact with a care coordinator instead of the face-to-face treatment with a cognitive-behavior therapist that has been a part of CCBT delivery in mental health settings. Novel features of this treatment program include: 1) fully detailed and replicable method for integrating clinician support with CCBT in primary care; 2) delivery of CCBT to a population with high percentage of disadvantaged patients; 3) integration of CCBT into the primary care delivery model; 4) highly interactive, multimedia computer program with adaptations for persons who may have lower levels of education or computer experience; 5) advanced cost-benefit analysis including data on actual health care utilization and costs; 6) exploration of moderators and predictors of treatment outcome.

Outcome will be assessed by measuring CCBT completion rate, comprehension of CBT concepts, and satisfaction with treatment; in addition to ratings of depressive symptoms, negative thoughts, and quality of life. The cost-effectiveness analysis and exploration of possible predictors of outcome should help clinicians, health care organizations, and others plan further dissemination of CCBT in primary care.

Study Type

Interventional

Enrollment (Actual)

176

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kentucky
      • Louisville, Kentucky, United States, 40202
        • University of Louisville, School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Patient Health Questionnaire score of 10 or above
  2. Age 18 or above

Exclusion Criteria:

  1. Refusal to provide informed consent
  2. Inability to read English text on computer screen
  3. Significant suicidal thoughts, intent, plan, or behavior reported on Columbia Suicide Severity Rating Scale
  4. Severe or poorly controlled medical disorders that would interfere with participation in CCBT (e.g., liver failure, terminal cancer)
  5. Dementia or other organic brain disorders that would prevent participation in CCBT
  6. Diagnosis of any psychotic disorder or bipolar disorder.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Computer-assisted CBT (CCBT)
12 weeks of CCBT for depression
Computer-assisted psychotherapy for depression using a computer program plus clinician support
Active Comparator: Treatment as Usual (TAU)
Treatment as usual by primary care physicians
Ordinary treatment for depression in primary care setting

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Health Questionnaire - 9
Time Frame: Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment period ends
Self-report scale for depression
Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment period ends

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Automatic Thoughts Questionnaire
Time Frame: Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment period ends
Self-report measure of negative cognitions
Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment period ends
Quality of Life Enjoyment and Satisfaction Questionnaire
Time Frame: Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment period ends
Self-report measure of quality of life
Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment period ends
Client Service Receipt Inventory
Time Frame: Change from baseline after 12 weeks of treatment and 3 and 6 months after 12-week treatment ends
Record of medical and related services
Change from baseline after 12 weeks of treatment and 3 and 6 months after 12-week treatment ends
Quality of Well Being Scale
Time Frame: Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment periods ends
Self-report measure of well-being
Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment periods ends
Patient Attitudes and Expectations Scale
Time Frame: Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment periods ends
Assessment of patient attitudes toward treatment
Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment periods ends
Generalized Anxiety Disorder - 7
Time Frame: Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment period ends
Self-report measure of anxiety
Change from baseline after 12 weeks of treatment and 3 and 6 months after the 12-week treatment period ends

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jesse Wright, M.D., Ph.D., University of Louisville

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2016

Primary Completion (Actual)

December 1, 2020

Study Completion (Actual)

December 1, 2020

Study Registration Dates

First Submitted

February 25, 2016

First Submitted That Met QC Criteria

March 1, 2016

First Posted (Estimated)

March 7, 2016

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 12, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 15.0640
  • R18HS024047 (U.S. AHRQ Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe